Andra AP fonden Sells 28,800 Shares of The Cooper Companies, Inc. $COO

Andra AP fonden lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 89.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,400 shares of the medical device company’s stock after selling 28,800 shares during the quarter. Andra AP fonden’s holdings in Cooper Companies were worth $242,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of COO. Resona Asset Management Co. Ltd. boosted its holdings in Cooper Companies by 7.9% in the second quarter. Resona Asset Management Co. Ltd. now owns 67,988 shares of the medical device company’s stock worth $4,838,000 after purchasing an additional 4,976 shares in the last quarter. South Dakota Investment Council acquired a new stake in shares of Cooper Companies in the second quarter worth about $78,000. State of Michigan Retirement System lifted its position in shares of Cooper Companies by 0.4% in the second quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company’s stock worth $3,867,000 after buying an additional 200 shares during the last quarter. Tredje AP fonden boosted its stake in shares of Cooper Companies by 92.2% during the 2nd quarter. Tredje AP fonden now owns 29,675 shares of the medical device company’s stock worth $2,112,000 after acquiring an additional 14,236 shares in the last quarter. Finally, Versor Investments LP acquired a new position in shares of Cooper Companies during the 2nd quarter valued at about $1,146,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $70.10 on Friday. The firm has a market capitalization of $13.94 billion, a PE ratio of 34.53, a PEG ratio of 1.83 and a beta of 1.02. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $106.63. The business’s 50 day moving average is $69.24 and its 200-day moving average is $72.64.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the company posted $0.96 earnings per share. Cooper Companies’s revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has authorized a share repurchase plan on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction dated Monday, September 29th. The shares were acquired at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the transaction, the director owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Albert G. White III purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average cost of $68.39 per share, with a total value of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. This represents a 4.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 17,975 shares of company stock worth $1,216,346 in the last ninety days. Company insiders own 1.98% of the company’s stock.

Analyst Ratings Changes

COO has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 target price on shares of Cooper Companies in a research report on Thursday, August 28th. Robert W. Baird reduced their price objective on shares of Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a research note on Thursday, August 28th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a report on Thursday, August 28th. Finally, BNP Paribas raised shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $84.77.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.